Anti-tumor fibrillar human serum albumin methods and compositions

A method comprising:

• administering to a subject having cancer selected from breast cancer, ovarian or cervical cancer, prostate cancer, lung cancer, and liver cancer, a therapeutically effective amount of fibrillar human serum albumin, wherein the fibrillar human serum albumin is produced by a method comprising:
• dissolving human serum albumin in a suitable detergent;
• sonicating the human serum albumin;
• applying the sonicated human serum albumin to a gel filtration column with a separation range above 70 kDa molecular weight;
• so as to promote column-induced fibrillar protein formation and to separate globular protein from fibrillar protein;
• eluting the fibrillar human serum albumin from the column with a buffer containing a low concentration of detergent;
• collecting eluent containing fibrillar human serum albumin from the column, and
• dialyzing the eluant to remove the detergent.